How much funding has Intrinsic Therapeutics raised?

Intrinsic Therapeutics has raised $130.6M in total funding, most recently a Growth Equity round.

Who are Intrinsic Therapeutics's investors?

Intrinsic Therapeutics's investors include New Enterprise Associates, Delos Capital, Questa Capital Management, Greenspring, Quadrille Capital.

When was Intrinsic Therapeutics founded?

Intrinsic Therapeutics was founded in 2002.

Where is Intrinsic Therapeutics headquartered?

Intrinsic Therapeutics is headquartered in Woburn, Massachusetts, United States.

What industry is Intrinsic Therapeutics in?

Intrinsic Therapeutics operates in Medical Devices, Spine Surgery, Healthcare, Medtech.

How many employees does Intrinsic Therapeutics have?

Intrinsic Therapeutics has 51-200 employees.

Intrinsic Therapeutics

Revolutionizing Herniated Disc Surgery | Barricaid

Woburn, United States · Founded 2002 · $130.6M raised

Medical Devices

Spine Surgery

Healthcare

Medtech

Headquarters: Woburn, Massachusetts
Employees: 51–200
Founded: 2002
Business Model: B2B

Website: barricaid.com
Total Funding: $130.6M
Last Round: $52.0M Growth EquityApr 2019
Rounds: 5

About

Intrinsic Therapeutics develops implantable devices to prevent recurrent disc herniation following lumbar discectomy surgery. Its flagship product, Barricaid, is an FDA Pre-Market Approved annular closure device that uses a flexible polymer mesh and titanium bone anchor to seal large annular defects. The device demonstrated superior outcomes to discectomy alone in a multicenter Level I randomized controlled trial, reducing reherniation and reoperation rates.

Summary

Intrinsic Therapeutics is a Medical Devices company based in Woburn, United States, founded in 2002. It has raised $130.6M in total across 5 rounds, most recently a $52.0M Growth Equity round in Apr 2019. Investors include New Enterprise Associates, Delos Capital and Questa Capital Management.

LinkedIn X (Twitter)